|
1
|
Zhang M, Ding Q, Bian C, Su J, Xin Y and
Jiang X: Progress on the molecular mechanism of portal vein tumor
thrombosis formation in hepatocellular carcinoma. Exp Cell Res.
426(113563)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pan J, Wang L, Gao F, An Y, Yin Y, Guo X,
Nery FG, Yoshida EM and Qi X: Epidemiology of portal vein
thrombosis in liver cirrhosis: A systematic review and
meta-analysis. Eur J Intern Med. 104:21–32. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Quirk M, Kim YH, Saab S and Lee EW:
Management of hepatocellular carcinoma with portal vein thrombosis.
World J Gastroenterol. 21:3462–3471. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Galasso L, Cerrito L, Termite F, Mignini
I, Esposto G, Borriello R, Ainora ME, Gasbarrini A and Zocco MA:
The molecular mechanisms of portal vein thrombosis in
hepatocellular carcinoma. Cancers (Basel). 16(3247)2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cavus UY, Yildirim S, Sönmez E, Ertan C
and Ozeke O: Prognostic value of neutrophil/lymphocyte ratio in
patients with pulmonary embolism. Turk J Med Sci. 44:50–55.
2014.PubMed/NCBI
|
|
6
|
Köse N, Yıldırım T, Akın F, Yıldırım SE
and Altun İ: Prognostic role of NLR, PLR, and LMR in patients with
pulmonary embolism. Bosn J Basic Med Sci. 20:248–253.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhao J, Liu K, Li S, Gao Y, Zhao L, Liu H,
Fang H, Song B and Xu Y: Neutrophil-to-lymphocyte ratio predicts
the outcome of cerebral venous thrombosis. Curr Neurovasc Res.
18:204–210. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hu J, Cai Z and Zhou Y: The association of
neutrophil-lymphocyte ratio with venous thromboembolism: A
systematic review and meta-analysis. Clin Appl Thromb Hemost.
28(10760296221130061)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cupp MA, Cariolou M, Tzoulaki I, Aune D,
Evangelou E and Berlanga-Taylor AJ: Neutrophil-to-lymphocyte ratio
and cancer prognosis. BMC Med. 18(360)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lin S, Hu S, Ran Y and Wu F:
Neutrophil-to-lymphocyte ratio predicts prognosis of patients with
hepatocellular carcinoma: A systematic review and meta-analysis.
Transl Cancer Res. 10:1667–1678. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Singal AG, Llovet JM, Yarchoan M, Mehta N,
Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA,
et al: AASLD practice guidance on prevention, diagnosis, and
treatment of hepatocellular carcinoma. Hepatology. 78:1922–1965.
2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tsoris A and Marlar CA: Use of the child
pugh score in liver disease. In: StatPearls. StatPearls Publishing,
Treasure Island, FL, 2025.
|
|
13
|
Han K and Kim JH: Transarterial
chemoembolization in hepatocellular carcinoma treatment: Barcelona
clinic liver cancer staging system. World J Gastroenterol.
21:10327–10335. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rosen RD and Sapra A: TNM Classification.
In: StatPearls. StatPearls Publishing, Treasure Island, FL,
2026.
|
|
15
|
Hsu CY, Liu PH, Lee YH, Hsia CY, Huang YH,
Lin HC, Chiou YY, Lee FY and Huo TI: Using serum AFP for prognostic
prediction in HCC. PLoS One. 10(e0118825)2015.
|
|
16
|
Chan MY, She WH, Dai WC, Tsang SHY, Chok
KSH, Chan ACY, Fung J, Lo CM and Cheung TT: Prognostic value of
preoperative AFP. Transl Gastroenterol Hepatol. 4(52)2019.
|
|
17
|
Liu H, Yang Y, Chen C, Wang L, Huang Q,
Zeng J, Lin K, Zeng Y, Guo P, Zhou W and Liu J: Reclassification of
tumor size for HBV-related HCC. World J Surg Oncol.
18(185)2020.
|
|
18
|
Jablonska J, Leschner S, Westphal K,
Lienenklaus S and Weiss S: Neutrophils responsive to IFN-β regulate
tumor angiogenesis. J Clin Invest. 120:1151–1164. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Branchford BR and Carpenter SL: The role
of inflammation in venous thromboembolism. Front Pediatr.
6(142)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Borazan E, Balık AA, Bozdağ Z, Arık MK,
Aytekin A, Yılmaz L, Elçi M and Başkonuş İ: NLR and prognosis in
colorectal cancer. Turk J Surg. 33:185–189. 2017.
|
|
21
|
Cushman M: Epidemiology and risk factors
for venous thrombosis. Semin Hematol. 44:62–69. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jaiswal M, LaRusso NF, Burgart LJ and
Gores GJ: Inflammatory cytokines induce DNA damage in
cholangiocarcinoma. Cancer Res. 60:184–190. 2000.PubMed/NCBI
|
|
25
|
Pfeiler S, Stark K, Massberg S and
Engelmann B: Propagation of thrombosis by neutrophils.
Haematologica. 102:206–213. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jain A, Chitturi S, Peters G and Yip D:
Atezolizumab and bevacizumab as first line therapy in advanced
hepatocellular carcinoma: Practical considerations in routine
clinical practice. World J Hepatol. 13:1132–1142. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li CB, Ning YT, Shen NY, Wang B, Xiao H
and Luo G: Systemic treatment of liver cancer: Current status and
future perspectives. World J Hepatol. 17(107520)2025.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Huang GQ, Zhu GQ, Liu YL, Wang LR,
Braddock M, Zheng MH and Zhou MT: NLR predicts mortality after
resection. Oncotarget. 7:5429–5439. 2016.
|
|
29
|
Li SH, Wang QX, Yang ZY, Jiang W, Li C,
Sun P, Wei W, Shi M and Guo RP: NLR in HCC with PVTT/HVTT. World J
Gastroenterol. 23:3122–3132. 2017.
|
|
30
|
Qian A, Zandi A, Bucciol R and Othman M:
The role of neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio as venous thromboembolism predictors
in breast cancer patients pre- and post-therapy. Blood Coagul
Fibrinolysis. 36:62–67. 2025.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Du P: Neutrophil-lymphocyte ratio is a
predictor of venous thromboembolism in gastric cancer patients.
Clin Lab 65: doi: 10.7754/Clin.Lab.2018.181005, 2019.
|
|
32
|
Selvaggio S, Brugaletta G, Abate A, Musso
C, Romano M, Di Raimondo D, Pirera E, Dattilo G and Signorelli SS:
Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio and
monocyte-to-HDL cholesterol ratio as helpful biomarkers for
patients hospitalized for deep vein thrombosis. Int J Mol Med.
51(52)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Signorelli SS: NLR, PLR, LMR in VTE with
cancer. Angiol Vasc Surg. 9:1–5. 2024.
|
|
34
|
Qian A, Zandi A, Bucciol R and Othman M:
NLR/PLR predict VTE in breast cancer. Blood Coagul Fibrinolysis.
36:62–67. 2025.
|
|
35
|
Go SI, Lee A, Lee US, Choi HJ, Kang MH,
Kang JH, Jeon KN, Park MJ, Kim SH and Lee GW: Clinical significance
of the neutrophil-lymphocyte ratio in venous thromboembolism
patients with lung cancer. Lung Cancer. 84:79–85. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Bruixola G, Niño OM, Diaz-Beveridge R,
Reche E, Salvador C, Escoin C, Akhoundova D, Segura A, Gimenez G
and Aparicio J: Baseline neutrophil-to-lymphocyte ratio (NLR) and
early toxicity as prognostic factors in advanced hepatocellular
carcinoma patients treated with sorafenib. J Clin Oncol. 33
(15_suppl)(e15159)2015.doi:10.1200/jco.2015.33.15_suppl.e15159.
|
|
37
|
Liao W, Zhang J, Zhu Q, Qin L, Yao W, Lei
B, Shi W, Yuan S, Tahir SA, Jin J and He S: Preoperative NLR in HCC
resection. Transl Oncol. 7:248–255. 2014.
|
|
38
|
Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu
L and Chen M: Postoperative NLR change after RFA. PLoS One.
8(e58184)2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fan W, Zhang Y, Wang Y, Yao X, Yang J and
Li J: NLR/PLR predict survival after TACE. PLoS One.
10(e0119312)2015.
|
|
40
|
Agopian VG, Harlander-Locke M, Zarrinpar
A, Kaldas FM, Farmer DG, Yersiz H, Finn RS, Tong M, Hiatt JR and
Busuttil RW: Nomogram for recurrence after LT. J Am Coll Surg.
220:416–427. 2015.
|
|
41
|
Fu YP, Ni XC, Yi Y, Cai XY, He HW, Wang
JX, Lu ZF, Han X, Cao Y, Zhou J, et al: Inflammation-based score
predicts survival. Medicine (Baltimore). 95(e2784)2016.
|
|
42
|
Lee JS, Chon YE, Kim BK, Park JY, Kim DY,
Ahn SH, Han KH, Kang W, Choi MS, Gwak GY, et al: AFP after complete
response to TACE. Yonsei Med J. 62:12–20. 2020.
|
|
43
|
Pan YX, Sun XQ, Hu ZL, Xie W, Nie KX, Fang
AP, Zhang YY, Fu YZ, Chen JB, Wang JC, et al: Prognostic values of
alpha-fetoprotein and des-gamma-carboxyprothrombin in
hepatocellular carcinoma in China: An analysis of 4792 patients. J
Hepatocell Carcinoma. 8:657–670. 2021.PubMed/NCBI View Article : Google Scholar :
doi:10.2147/JHC.S316223.
|
|
44
|
Abdelhamed W, Shousha H and El-Kassas M:
Portal vein tumor thrombosis in HCC. Liver Res. 8:141–151.
2024.
|
|
45
|
Liu L, Liu D, He W and Zhang W: Incidence
of thrombosis in patients with hepatocellular carcinoma: systematic
review and meta-analysis. J Thromb Thrombolysis. 58:925–936.
2025.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Königsbrügge O, Posch F, Riedl J, Reitter
EM, Zielinski C, Pabinger I and Ay C: Association between decreased
serum albumin with risk of venous thromboembolism and mortality in
cancer patients. Oncologist. 21:252–257. 2016.PubMed/NCBI View Article : Google Scholar
|
